Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The investigators performed a multi-centered, randomized, placebo-controlled, prospective
clinical trial on the effect of comprehensive rehabilitation program to improve quality of
life(QOL) and long-term survival of postoperative patients with early lung cancer. The
investigators plan to enroll 236 cases in 3 years (118 cases for rehabilitation training plus
traditional Chinese medicine (TCM), 118 cases for rehabilitation education plus placebo),
expecting that comprehensive rehabilitation program has a better efficacy on improving QOL
and long-term survival.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborators:
Huadong Hospital Shanghai Cancer Hospital, China Shanghai Chest Hospital Shanghai Pulmonary Hospital, Shanghai, China